Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort

J Korean Med Sci. 2021 Sep 13;36(36):e246. doi: 10.3346/jkms.2021.36.e246.

Abstract

In 2017, the Korean government launched an unprecedentedly large-scaled latent tuberculosis infection (LTBI) screening project which covered more than a million individuals in congregate settings. A total of 1,047,689 participants of source population (n = 2,336,157) underwent LTBI testing from 2017 to 2018. The overall LTBI test uptake rate during this project was 44.8%. Workers in daycare centers (83.5%) and kindergartens (78.9%) showed high participation rate. A total of 1,012,206 individuals with valid results of interferon-gamma release assay (IGRA) were selected to constitute the IGRA cohort. Most of the enrolled participants in the IGRA cohort were in their working age. Approximately, three-quarters of total enrolled population were female. Investigating the LTBI prevalence, stages of LTBI care cascade, natural history of LTBI, efficacy of LTBI treatment and cost-effectiveness of LTBI screening are feasible within this IGRA cohort.

Keywords: Interferon-gamma Release Tests; Latent Tuberculosis; Mass Screening; Republic of Korea.

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use
  • Cohort Studies
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Interferon-gamma Release Tests / methods*
  • Latent Tuberculosis / diagnosis*
  • Latent Tuberculosis / drug therapy
  • Male
  • Mass Screening / economics*
  • Middle Aged
  • Prevalence
  • Republic of Korea

Substances

  • Antitubercular Agents